Drawing for CERTUS

USPTO serial 98199938

CERTUS

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ELTON, DAVID JONATHAN
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with CERTUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $697*

Plus Government fees of $375

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Cole

David Cole CADWALADER, WICKERSHAM & TAFT LLP200 LIBERTY STREETNEW YORK, NY 10281United States

Goods and services

ClassDescriptionStatusFirst use
009Recorded medical software for the automated diagnosis of disease conditions from analysis of medical dataACTIVE—
035Data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, for business purposes; business consulting and business analysis services relating to information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publicationsACTIVE—
042Computer programming consultancy; Computer software consulting; Advanced product research in the field of artificial intelligence; Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare access to a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; platform-as-a-service (PaaS)featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; Scientific and technological services, namely, scientific research and analysis, in the fields of medicine, health and wellness; design and development of computer hardware and computer software; biomedical research; computer software development; scientific laboratory services; provision of information relating to medical and scientific research in the field of pharmaceutical products; computer software programming for others; all of the foregoing services provided in the fields of medicine, health, fitness, exercise and wellnessACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 4, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 3, 2026EX3GSOU EXTENSION 3 GRANTED—
Mar 3, 2026EXT3SOU EXTENSION 3 FILED—
Mar 3, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 13, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 12, 2025EX2GSOU EXTENSION 2 GRANTED—
Aug 12, 2025EXT2SOU EXTENSION 2 FILED—
Aug 12, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 21, 2025EX1GSOU EXTENSION 1 GRANTED—
Mar 20, 2025EXT1SOU EXTENSION 1 FILED—
Mar 20, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 22, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 27, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 27, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 18, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 18, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 18, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 18, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 18, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2024NREVNOTICE OF REVIVAL - E-MAILED—
Jun 4, 2024PETGPETITION TO REVIVE-GRANTED—
Jun 4, 2024PROATEAS PETITION TO REVIVE RECEIVED—
Mar 2, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 2, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 2, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2023DOCKASSIGNED TO EXAMINER—
Oct 11, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 30, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance